Konarska L, Wiesmann U, von Fellenberg R, Colombo J P
Enzyme. 1983;29(1):44-53. doi: 10.1159/000469602.
Arginase deficiency is an inborn error of the last step in the urea cycle and leads to profound hyperargininemia. The enzyme deficiency has been demonstrated in the liver and red blood cells. In cultured patient fibroblasts, the activity is normal. Arginase exists in multiple molecular forms only one of which is missing in hyperargininemic patients. In fibroblasts, three arginase isoenzymes can be demonstrated by DEAE-cellulose column chromatography, two by electrophoresis and by immunoprecipitation methods. From the present data, it is improbable that part of the A1 isoenzyme in fibroblasts originates from fetal calf serum arginase which supplements the culture media. None of the techniques for the separation and analyses of arginase isoenzyme allows to differentiate between the normal and the arginase-deficient phenotype. A possible explanation would be that the defect in A1 arginase observed in the liver is the result of a regulatory defect.
精氨酸酶缺乏症是尿素循环最后一步的先天性代谢缺陷,可导致严重的高精氨酸血症。已在肝脏和红细胞中证实存在该酶缺乏。在培养的患者成纤维细胞中,酶活性正常。精氨酸酶以多种分子形式存在,高精氨酸血症患者仅缺失其中一种。在成纤维细胞中,通过DEAE - 纤维素柱层析可显示三种精氨酸酶同工酶,通过电泳和免疫沉淀法可显示两种。根据目前的数据,成纤维细胞中的部分A1同工酶不太可能源自补充培养基的胎牛血清精氨酸酶。用于精氨酸酶同工酶分离和分析的技术均无法区分正常和精氨酸酶缺乏的表型。一种可能的解释是,在肝脏中观察到的A1精氨酸酶缺陷是调节缺陷的结果。